Earnings Call · Q2 FY2021·2021-07-21

Q2 21EPS +14.71%·Rev n/aQ1 21EPS +3.94%·Rev n/aQ4 20EPS +7.41%·Rev n/aQ3 20EPS +7.69%·Rev n/a⚠ consensus missing

ABBOTT LABORATORIES ABT

Scott Leinenweber — Vice President, Investor Relations

Robert Ford — President and Chief Executive Officer

Since the beginning of the pandemic, we've seen 2 factors positively impact Adult Nutrition demand

Robert Funck — Executive Vice President, Finance, and Chief Financial Officer

Robert Hopkins — Analyst

Robert Marcus — Analyst

Vijay Kumar — Analyst

+0.1%1d on move date3d−1.2%5d+0.9%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABT calls or request research access.

More ABT calls Browse calls Request research access